Catalyst Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.9K | Sell |
157
-45
| -22% | -$20K | ﹤0.01% | 377 |
|
|
2025
Q1 | $97.9K | Sell |
202
-9,343
| -98% | -$4.53M | ﹤0.01% | 302 |
|
|
2024
Q4 | $3.84M | Sell |
9,545
-225
| -2% | -$90.6K | 0.08% | 82 |
|
|
2024
Q3 | $4.54M | Sell |
9,770
-325
| -3% | -$151K | 0.1% | 78 |
|
|
2024
Q2 | $4.73M | Sell |
10,095
-48
| -0.5% | -$22.5K | 0.11% | 69 |
|
|
2024
Q1 | $4.24M | Sell |
10,143
-174
| -2% | -$72.7K | 0.1% | 77 |
|
|
2023
Q4 | $4.2M | Sell |
10,317
-798
| -7% | -$325K | 0.11% | 73 |
|
|
2023
Q3 | $3.87M | Sell |
11,115
-327
| -3% | -$114K | 0.11% | 77 |
|
|
2023
Q2 | $4.03M | Sell |
11,442
-605
| -5% | -$213K | 0.12% | 75 |
|
|
2023
Q1 | $3.8M | Buy |
12,047
+1,022
| +9% | +$322K | 0.12% | 76 |
|
|
2022
Q4 | $3.18M | Buy |
11,025
+10,820
| +5,278% | +$3.12M | 0.1% | 88 |
|
|
2022
Q3 | $59K | Buy |
205
+2
| +1% | +$576 | ﹤0.01% | 252 |
|
|
2022
Q2 | $57K | Buy |
203
+28
| +16% | +$7.86K | ﹤0.01% | 272 |
|
|
2022
Q1 | $46K | Buy |
175
+31
| +22% | +$8.15K | ﹤0.01% | 312 |
|
|
2021
Q4 | $32K | Sell |
144
-12
| -8% | -$2.67K | ﹤0.01% | 322 |
|
|
2021
Q3 | $28K | Sell |
156
-3
| -2% | -$538 | ﹤0.01% | 326 |
|
|
2021
Q2 | $32K | Buy |
159
+5
| +3% | +$1.01K | ﹤0.01% | 333 |
|
|
2021
Q1 | $33K | Sell |
154
-29
| -16% | -$6.21K | ﹤0.01% | 297 |
|
|
2020
Q4 | $43K | Sell |
183
-28,667
| -99% | -$6.74M | ﹤0.01% | 275 |
|
|
2020
Q3 | $7.85M | Sell |
28,850
-1,850
| -6% | -$503K | 0.44% | 32 |
|
|
2020
Q2 | $8.91M | Sell |
30,700
-2,800
| -8% | -$813K | 0.46% | 28 |
|
|
2020
Q1 | $7.97M | Buy |
+33,500
| New | +$7.97M | 0.4% | 29 |
|